Open AccessMycoplasma pneumoniae co-infection with SARS-CoV-2: A case report
Author(s) -
Rama Chaudhry,
K R Sreenath,
E V Vinayaraj,
Biswajeet Sahoo,
Mohan Narayanan,
Kamini Kiran,
Priyam Batra,
Nisha Rathor,
Sheetal Singh,
Anant Mohan,
Sushma Bhatnagar
Publication year - 2021
Publication title -
access microbiology
Language(s) - English
Resource type - Journals
ISSN - 2516-8290
DOI - 10.1099/acmi.0.000212
Subject(s) - mycoplasma pneumoniae , pneumonia , medicine , pathogen , atypical pneumonia , outbreak , covid-19 , mycoplasmataceae , intensive care medicine , virology , mycoplasma , immunology , microbiology and biotechnology , biology , mollicutes , infectious disease (medical specialty) , disease
We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) andMycoplasma pneumoniaein a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 andM. pneumoniaeis infrequently reported in the literature. Broader testing for common respiratory pathogens should be performed in severe COVID-19 cases to rule out other concurrent infections. Early identification of co-existing respiratory pathogens could provide pathogen-directed therapy, and can save patient lives during the ongoing COVID-19 outbreak.